Considerable variations have been observed in the postnatal management and outcomes of hemolytic disease of the fetus and ...

A recent study showed limited data exist on the risks associated with anti-G during pregnancy, including the development of ...

A recent review showed Rhesus D (RhD)-negative red blood cell (RBC) products should be the first choice for women who require ...

In pregnancies at risk of hemolytic disease of the fetus and newborn (HDFN), amniocentesis is used to identify the fetus’s ...

Learn more about what Rh immunoglobulin (RhIG) treatment is, how it is administered and how it works to prevent HDFN.

Learn about why delayed hemolysis occurs, how it can affect newborns diagnosed with HDFN and how it can be treated.

Erin Collins was 37 weeks and four days pregnant in 2019 when—after an agonizing 32 hours in labor—she gave birth to B.B., ...

A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec infusion.

Researchers stated that greater consensus is needed across the healthcare field on managing and treating HDFN. There is a greater need for consensus in the management of hemolytic disease of the fetus ...